Cadherin-6

Cadherin-6

Cadherin-6 Informations sur la molécule

Molecule Name
Cadherin-6
Alias de la molécule
CDH6,CAD6,KCAD,K-cadherin,Cadherin-6
Drug Development Progress
Nombre de médicaments cliniques5
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 3 Clinical
Alias de la cible
Kidney cadherin,K-cadherin,Cadherin 6, Type 2, K-Cadherin (Fetal Kidney),K-Cadherin,Cadherin-6,Kidney Cadherin,CAD6,KCAD
Contexte de la molécule
Cadherin-6 (CDH6) is also known as Kidney cadherin (K-cadherin or KCAD), is a a type II classical cadherin from the cadherin superfamily. Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. CDH6 / KCAD contains five cadherin domains. CDH6 is highly expressed in brain, cerebellum, and kidney. Lung, pancreas, and gastric mucosa show a weak expression and also expressed in certain liver and kidney carcinomas.

Cadherin-6 Liste de produits

Species
  • Human(10)
  • Cynomolgus / Rhesus macaque(2)
  • Mouse(1)
  • Rat(1)
Tag
  • Fc Tag(9)
  • His Tag(4)
  • His Tag & Avi Tag(1)
Host
  • HEK293(14)
Conjugate
  • Unconjugated(13)
  • Biotin-labeled(1)
Grade
  • RUO(14)
Low Endotoxin
  • Yes(3)
  • No(11)
You Have Viewed 1-10 Of 14 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
CDH6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Renal cell carcinoma
Nom du projet
CDH6 mAb - 01
Phase du projet
PCC
Type de molécule
Monoclonal
Source de molécule
Humanized Mouse
Domain thérapeutique
Solid Tumor
Indication
Ovarian cancer,Renal cell carcinoma
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Raludotatug deruxtecanDS-6000a; DS6000a; DS-6000; R-DXd; MK-5909Phase 3 ClinicalDaiichi Sankyo Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours
Details
QLS-5133QLS-5133; QLS5133Phase 2 ClinicalQilu Pharmaceutical Co Ltd
Solid tumours
Details
HS-20124HS-20124; HS20124Phase 1 ClinicalHansoh BioMedical R&D Company
Solid tumours
Details
SIM-0505SIM-0505Phase 1 ClinicalHainan Xiansheng Re Ming Pharmaceutical Co Ltd
Solid tumours
Details
AMT-707AMT-707; CUSP-06Phase 1 ClinicalMultitude Therapeutics Inc
Carcinoma, Renal Cell; Cholangiocarcinoma; Ovarian Neoplasms; Solid tumours
Details
Customer Reviews